0001104659-20-046080.txt : 20200413
0001104659-20-046080.hdr.sgml : 20200413
20200413202245
ACCESSION NUMBER: 0001104659-20-046080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200409
FILED AS OF DATE: 20200413
DATE AS OF CHANGE: 20200413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sirard Cynthia
CENTRAL INDEX KEY: 0001808408
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 20789778
MAIL ADDRESS:
STREET 1: C/O LEAP THERAPEUTICS, INC.
STREET 2: 47 THORNDIKE STREET, SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
a4.xml
4
X0306
4
2020-04-09
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001808408
Sirard Cynthia
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET SUITE B1-1
CAMBRIDGE
MA
02141
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
1.69
2020-04-09
4
A
0
50000
0
A
2030-04-09
Common Stock
50000
50000
D
The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one-month anniversary of April 9, 2020, the Vesting Start Date.
/s/ Douglas E. Onsi as attorney-in-fact for Cynthia Sirard
2020-04-13